Firms plan African solar-energy project

The massive solar-power facility in North Africa could satisfy 15 percent of Europe's energy needs by 2050.

July 14, 2009 11:51


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


A consortium of 12 European businesses outlined an ambitious plan Monday to build a massive solar-power facility in North Africa that they said could satisfy 15 percent of Europe's energy needs by 2050. The so-called Desertec project involves, among others, German industrial conglomerate Siemens AG, power companies RWE AG and E.ON AG, reinsurer Munich Re AG, Deutsche Bank AG and Swiss-based electrical engineering firm ABB. The project would be based largely on solar thermal-power plants, which use mirrors to focus the sun's energy to heat a special oil, create steam and power generators. Such power plants are already running in the US, Spain and elsewhere. Power would be transmitted to Europe across a new 3,000-kilometer network.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection